Concepedia

Shawn Flanagan

SF

Statistics

Publications

9

Citations

464

H-Index

9

Active since

2002

Affiliations

University of Connecticut(Current)

Eli Lilly (United States)

Pennsylvania State University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Shawn Flanagan is an author at University of Connecticut specializing in medicine, exercise physiology, and kinesiology.

Top concepts

Publications per year

2002–2017

9

Publications

9

Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

Mark Fineman, Shawn Flanagan, Kristin Taylor et al. · Clinical Pharmacokinetics · 2010 · 134 citations

, , +8

Single‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid

Shawn Flanagan, Edward Fang, Kelly A. Muñoz et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2014 · 85 citations · Full text

Absorption, Distribution, Metabolism, and Excretion of the Novel Antibacterial Prodrug Tedizolid Phosphate

Voon Ong, Shawn Flanagan, Edward Fang et al. · Drug Metabolism and Disposition · 2014 · 76 citations

Recovery From Injury in Sport: Considerations in the Transition From Medical Care to Performance Care

William J. Kraemer, Craig R. Denegar, Shawn Flanagan · Sports Health A Multidisciplinary Approach · 2009 · 55 citations

, , +21

Contributions of Saturable Active Secretion, Passive Transcellular, and Paracellular Diffusion to the Overall Transport of Furosemide Across Adenocarcinoma (Caco-2) Cells

Shawn Flanagan, Lpori H. Takahashi, Xiaoli Liu et al. · Journal of Pharmaceutical Sciences · 2002 · 39 citations

, , +12

1–5 of 9